• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Spherix Incorporated (SPEX) - Financial and Strategic SWOT Analysis Review - Product Image

Spherix Incorporated (SPEX) - Financial and Strategic SWOT Analysis Review

  • Published: May 2013
  • Region: Global
  • 40 pages
  • GlobalData

FEATURED COMPANIES

  • Eli Lilly and Company
  • ICF International, Inc.
  • Novo Nordisk A/S
  • Sanofi
  • Zaptronix Limited
  • MORE

Spherix Incorporated (SPEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – READ MORE >

List of Tables
List of Figures
Section 1 - About the Company
Spherix Incorporated - Key Facts
Spherix Incorporated - Key Employees
Spherix Incorporated - Key Employee Biographies
Spherix Incorporated - Major Products and Services
Spherix Incorporated - Pharmaceutical Pipeline Products Data
Spherix Incorporated, Pipeline Products by Therapy Area
Spherix Incorporated, Pipeline Products by Development Phase
Spherix Incorporated - History
Spherix Incorporated - Company Statement
Spherix Incorporated - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Spherix Incorporated - Business Description
Spherix Incorporated - SWOT Analysis
SWOT Analysis - Overview
Spherix Incorporated - Strengths
Strength - Lead Drug Candidate - SPX106T
Strength - Strategic Outlook
Spherix Incorporated - Weaknesses
Weakness - Reliance on Third Parties
Weakness - History of Losses
Spherix Incorporated - Opportunities
Opportunity - Key Business Initiatives
Opportunity - Rising Healthcare Expenditure in the US
Opportunity - Market for Diabetes
Spherix Incorporated - Threats
Threat - Tightening of FDA’s Regulatory Oversight
Threat - Uncertain R&D Outcomes
Threat - Competitive Pressures
Spherix Incorporated - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Spherix Incorporated, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Spherix Incorporated, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Spherix Incorporated, Recent Deals Summary
Section 5 – Company’s Recent Developments
Spherix Incorporated, Recent Developments
Feb 28, 2013: Spherix Names Harvey Kesner As Interim CEO
Dec 03, 2012: Spherix Announces Restructuring
Nov 15, 2012: Spherix Reports Q3 2012 Results
Aug 13, 2012: Spherix Reports Q2 2012 Results
May 15, 2012: Spherix Reports Q1 2012 Results
Mar 28, 2012: Spherix Reports 2011 Results
Mar 08, 2012: Spherix To Present New Work On Lipoproteins And Atheromas At Pittcon Conference
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
Spherix Incorporated, Key Facts
Spherix Incorporated, Key Employees
Spherix Incorporated, Key Employee Biographies
Spherix Incorporated, Major Products and Services
Spherix Incorporated, Number of Pipeline Products by Therapy Area
Spherix Incorporated, Number of Pipeline Products by Development Stage
Spherix Incorporated, Pipeline Products By Therapy Area and Development Phase
Spherix Incorporated, History
Spherix Incorporated, Subsidiaries
Spherix Incorporated, Key Competitors
Spherix Incorporated, Ratios based on current share price
Spherix Incorporated, Annual Ratios
Spherix Incorporated, Interim Ratios
Spherix Incorporated, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Spherix Incorporated, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Spherix Incorporated, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Spherix Incorporated, Pipeline Products by Therapy Area
Spherix Incorporated, Pipeline Products by Development Phase
Spherix Incorporated, Performance Chart (2008 - 2012)
Spherix Incorporated, Ratio Charts
Spherix Incorporated, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Spherix Incorporated, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013

Zaptronix Limited
Sanofi
Eli Lilly and Company
Novo Nordisk A/S
ICF International, Inc.

Note: Product cover images may vary from those shown

RELATED PRODUCTS